Time to think about neonatal outcome in assisted reproductive technology
Assisted reproductive technology (ART), originally called in vitro fertilization (IVF), has been with us for forty years. During all this time efforts have mainly been targeted at increasing outcome, first expressed as pregnancy rates and more recently, as overall ART yield or live-birth rates. Of all the steps taken for improving ART outcome, the introduction of ovarian stimulation (OS) nearly from the inception of ART has been the single most effective measure ever implemented. Originally, fears existed that OS might alter oocyte quality, as it leads to recuperate, and inseminate, oocytes bound for atresia.
Source: fertstert.org
Time to think about neonatal outcome in assisted reproductive technology
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection
Be First to Comment